Aged; Endosonography/methods; Female; Humans; Lung Neoplasms/pathology/radionuclide imaging/ultrasonography; Lymphatic Metastasis/radionuclide imaging/ultrasonography; Male; Mediastinum/pathology/radionuclide imaging/ultrasonography; Middle Aged; Neoplasm Staging; Positron-Emission Tomography/methods; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric
Abstract :
[en] SUMMARY: In the staging of lung cancer with positron emission tomography (PET) positive mediastinal lymph nodes, tissue sampling is required. The performance of transbronchial needle aspiration (TBNA) using linear endobronchial ultrasound (real-time EBUS-TBNA) under local anaesthesia and the value of PET for prediction of pathological results were assessed in that setting. The number of eluded surgical procedures was evaluated. All consecutive patients with suspected/proven lung cancers and FDG-PET positive mediastinal adenopathy were included. If no diagnosis was reached, further surgical sampling was required. Lymph node SUVmax (maximum standardized uptake value) was assessed in patients whose PET was performed in the leading centre. One hundred and six patients were included. The average number of TBNA samples per patient was 4.9+/-1.1. The prevalence of lymph node metastasis was 58%. Sensitivity, accuracy and negative predictive value of EBUS-TBNA in the staging of mediastinal hot spots were 95, 97 and 91%. Patients without malignant lymph node involvement showed lower SUVmax (respective median values of 3.7 and 10.0; p<0.0001). Surgical procedures were eluded in 56% of the patients. Real-time EBUS-TBNA should be preferred over mediastinoscopy as the first step procedure in the staging of PET mediastinal hot spots in lung cancer patients. In case of negative EBUS, surgical staging procedure should be undertaken. The addition of SUVmax cut-off may allow further refinement but needs validation.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Bauwens, Olivier
Dusart, Michelle
Pierard, Philippe
Faber, Jean
Prigogine, Thierry
Duysinx, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Nguyen, Bich
Paesmans, Marianne
Sculier, Jean-Paul
Ninane, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > Exploitation technique-maintenance des bâtiments
Language :
English
Title :
Endobronchial ultrasound and value of PET for prediction of pathological results of mediastinal hot spots in lung cancer patients.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Ohta Y., Shimizu Y., Minato H., Matsumoto I., Oda M., Watanabe G., et al. Results of initial operations in non-small cell lung cancer patients with single-level N2 disease. Ann Thorac Surg 81 (2006) 427-433
Gould M.K., Kuschner W.G., Rydzak C.E., Maclean C.C., Demas A.N., Shigemitsu H., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 139 (2003) 879-892
Silvestri G.A., Tanoue L.T., Margolis M.L., Barker J., Detterbeck F., and American College of Chest Physicians. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 123 (2003) 147S-156S
van Tinteren H., Hoekstra O.S., Smit E.F., van den Bergh J.H., Schreurs A.J., Stallaert R.A., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359 (2002) 1388-1393
Toloza E.M., Harpole L., Detterbeck F., and McCrory D.C. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 157S-166S
Luke W.P., Pearson F.G., and Todd T.R.J. Prospective evaluation of mediastinoscopy. J Thor Cardiovasc Surg 91 (1986) 53-56
Krasnik M., Vilman P., Larsen S.S., and Jacobsen G.K. Preliminary experience with a new method of endoscopic transbronchial real time ultrasound guided biopsy for diagnosis of mediastinal and hilar lesions. Thorax 58 (2003) 1083-1086
Yasufuku K., Chiyo M., Sekine Y., Chhajed P.N., Shibuya K., Iizasa T., et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest 126 (2004) 122-128
Rintoul R.C., Skwarski K.M., Murchison J.T., Wallace W.A., Walker W.S., and Penman I.D. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging. Eur Respir J 25 (2005) 416-421
Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., Dupont P.J., Bogaert J., Maes A., et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16 (1998) 2142-2149
Vermylen P., Pierard P., Roufosse C., Bosschaerts T., Verhest A., Sculier J.P., et al. Detection of bronchial preneoplastic lesions and early lung cancer with fluorescence bronchoscopy: a study about its ambulatory feasibility under local anesthesia. Lung Cancer 25 (1999) 161-168
Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
Annema J.T., Versteegh M.I., Veselic M., Voigt P., and Rabe K.F. Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging. J Clin Oncol 23 (2005) 8357-8361
Faber J., Pierard P., Prigogine T., Dusart M., Haller A., Bosschaerts T., et al. Endobronchial ultrasound and PET positive nodes in bronchial carcinoma. Rev Mal Respir 23 1 (2006) 37-42
Plat G., Pierard P., Haller A., Hutsebaut J., Faber J., Dusart M., et al. Endobronchial ultrasound and PET positive mediastinal lymph nodes. Eur Respir J 27 (2006) 276-361
Herth F., Becker H.D., and Ernst A. Conventional vs. endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest 125 (2004) 322-325
Harrow E.M., Abi-Saleh W., Blum J., Harkin T., Gasparini S., Addrizzo-Harris D.J., et al. The utility of transbronchial needle aspiration in the staging of bronchogenic carcinoma. Am J Respir Crit Care Med 161 2 Pt 1 (2000) 601-607
Kramer H., van Putten J.W.G., Post W.J., van Dullemen H.M., Bongaerts A.H.H., Pruim J., et al. Oesophageal endoscopic ultrasound with fine needle aspiration improves and simplifies the staging of lung cancer. Thorax 59 (2004) 596-601
Annema J.T., Hoekstra O.S., Smit E.F., Veselic M., Versteegh M.I.M., and Rabe K.F. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA. Lung Cancer 44 (2004) 53-60
Eloubeidi M.A., Cerfolio R.J., Chen V.K., Desmond R., Syed S., and Ojha B. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thorac Surg 79 1 (2005) 263-268
Herth F.J., Lunn W., Eberhardt R., Becker H.D., and Ernst A. Transbronchial versus transesophageal ultrasound-guided aspiration of enlarged mediastinal lymph nodes. Am J Respir Crit Care Med 171 (2005) 1164-1167
Bueno R., Richards W.G., Swanson S.J., Jaklitsch M.T., Lukanich J.M., Mentzer S.J., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2000) 1826-1831
Voltolini L., Luzzi L., Ghiribelli C., Paladini P., Di Bisceglie M., and Gotti G. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy. Eur J Cardiothorac Surg 20 (2001) 1106-1112
Sawabata N., Keller S.M., Matsumura A., Kawashima O., Hirono T., Osaka Y., et al. The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer. Lung Cancer 42 (2003) 69-78
Betticher D.C., HSU Schmitz S.F., Totsch M., Hansen E., Joss C., von Briel C., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 9 (2003) 1752-1759
Mateu-Navarro M., Rami-Porta R., Bastus-Piulats R., Cirera-Nogueras L., and Gonzalez-Pont G. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg 70 (2000) 391-395
Van Schil P., van der School J., and Poniewierski J. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer 37 (2002) 281-285
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.